Catinazzo Thomas Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
40
Insider Sells Sum
$6.3M

Insider Activity of Catinazzo Thomas

According to the SEC Form 4 filings, Catinazzo Thomas, being in a position of

  1. Chief Financial Officer at Relay Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 214511 share for $3.37M,
    over all time since 2021-03-30, has bought 0 shares, and sold 616405 shares for $9.9M.

Biography of Catinazzo Thomas

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $3,374,16914100

Comparison of Insiders on Amount of Buys and Sells

2026-10-28SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
1,469
0.0006%
$18.62$27,353-9.12%
2026-10-06SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
17,717
0.008%
$18.59$329,322-4.14%
2026-09-08SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
17,717
0.0087%
$18.94$335,560-4%
2026-08-14SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
17,717
0.0087%
$19.74$349,734-6.42%
2026-07-28SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
1,459
0.0008%
$18.61$27,152+3.01%
2026-07-06SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
17,717
0.01%
$18.69$331,131-0.05%
2026-06-22SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
69,277
0.0389%
$16.98$1.18M+9.03%
2026-05-14SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
17,717
0.009%
$12.86$227,841+44.84%
2026-04-28SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
972
0.0006%
$14.79$14,376+41.06%
2026-04-09SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
1,800
0.0011%
$15.00$27,000+21.23%
2026-04-07SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
17,717
0.0096%
$13.01$230,498+34.64%
2026-03-09SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
17,717
0.0101%
$10.06$178,233+74.65%
2026-01-28SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
1,695
0.001%
$8.45$14,323+115.82%
2026-01-27SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
13,820
0.0071%
$7.62$105,308+93.59%
2025-10-28SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
21,664
0.0136%
$7.29$157,931+79.26%
2025-07-29SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
18,380
0.0109%
$3.68$67,638+134.25%
2025-07-28SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
1,701
0.001%
$3.74$6,362+129.19%
2025-04-30SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
12,943
0.0068%
$3.00$38,829+95.5%
2025-04-29SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
3,558
0.0022%
$3.23$11,492+110%
2025-04-28SaleRelay Therapeutics, Inc.
RLAY
Chief Financial Officer
2,690
0.0016%
$3.17$8,527+99.39%
Total: 57
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.